Other states plan to gradually expand visits to senior citizens next month. For example, Ohio will start vaccinating people 80 years and older next week, vaccinating people 70 years and older from February 1, and vaccinating people 65 years and older from February 8 . The registration portal quickly collapsed, and people spent a lot of time on the phone or in long lines, but to no avail.
Two vaccine production companies with emergency approvals, Pfizer and Moderna, are both increasing production. Pfizer CEO Dr. Albert Burla said in an interview with CNBC that Pfizer and its German partner BioNTech have increased the estimated global production this year from 1
He said: “We now have more things than they can use now.”
The CDC recommended last month that after vaccinating health care workers and residents of long-term care facilities, states should vaccinate people over the age of 75 and certain “frontline” workers who cannot work from home. The Centers for Disease Control and Prevention recommends that only after this, people aged 65 to 74 and adults with high-risk medical conditions of all ages should be resorted to. The CDC recommendations are not binding, but many states have followed them to a large extent, and demand still far exceeds supply.
The advisory group that made the recommendations emphasized that basic workers are usually low-paid people of color, and they are particularly hard hit by the virus.
Dr. Marcus Plescia, Chief Medical Officer of the National and Territorial Health Officials Association, said: “Many of our members feel that this is too fast. “We will adopt a first-come, first-served vaccine distribution method, but it will be unfair. “
Mr. Biden is expected to announce the details of his vaccination plan this week, including a mass vaccination clinic supported by the federal government. The Biden transition team declined to comment on the new Trump administration policy on Tuesday. But people familiar with the plan for the president-elect say that Mr. Biden has also planned to expand the universe of those who are eligible for vaccination.
Mr. Azar said that when the Trump administration is confident in the supply chain, it always expects to shift from inhibitors.